| Date Filed | Type | Description |
| 01/06/2020 |
4
| BUCHEN DAVID A (SVP, Chief Legal Officer) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 8,188 shares
@ $4.72, valued at
$38.6k
Exercised 27,614 restricted stock units
@ $0 |
|
| 01/07/2019 |
4
| BUCHEN DAVID A (SVP, Chief Legal Officer) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Granted 227,273 options
@ $13.58, valued at
$3.1M
Granted 110,457 restricted stock units
@ $0 |
|
| 01/07/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/09/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/03/2014 |
4
| BUCHEN DAVID A (See Remarks) has filed a Form 4 on Actavis plc|
Txns:
| Granted 7,845 shares
@ $0
Granted 24,210 options to buy
@ $0
Granted 22,032 options to buy
@ $224, valued at
$4.9M
|
|
| 05/13/2014 |
4
| BUCHEN DAVID A (Chief Legal Officer-Global&Sec) has filed a Form 4 on Actavis plc|
Txns:
| Granted 2,960 shares
@ $197.05, valued at
$583.3k
|
|
| 11/13/2013 |
4
| BUCHEN DAVID A (Chief Legal Officer-Global&Sec) has filed a Form 4 on Actavis plc|
Txns:
| Sold 30,000 shares
@ $159.3, valued at
$4.8M
|
|
| 10/03/2013 |
4
| BUCHEN DAVID A (Chief Legal Officer-Global&Sec) has filed a Form 4 on Actavis plc|
Txns:
| Granted 89,966 shares
@ $0 |
|
| 10/03/2013 |
3
| BUCHEN DAVID A (Chief Legal Officer-Global&Sec) has filed a Form 3 on Actavis plc |
| 10/02/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/03/2013 |
4
| BUCHEN DAVID A (Chief Legal Officer-Global&Sec) has filed a Form 4 on Actavis, Inc.|
Txns:
| Sold 10,000 shares
@ $135.5579, valued at
$1.4M
Exercised 5,000 options to buy
@ $35.11, valued at
$175.6k
Exercised 5,000 options to buy
@ $25.64, valued at
$128.2k
|
|
| 08/13/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/18/2013 |
4
| BUCHEN DAVID A (Chief Legal Officer-Global&Sec) has filed a Form 4 on Actavis, Inc.|
Txns:
| Paid exercise price by delivering 933 shares
@ $91.59, valued at
$85.5k
|
|
| 03/13/2013 |
4
| BUCHEN DAVID A (Chief Legal Officer-Global&Sec) has filed a Form 4 on Actavis, Inc.|
Txns:
| Sold 8,000 shares
@ $89, valued at
$712k
Exercised 1,600 options to buy
@ $38.92, valued at
$62.3k
Exercised 6,400 options to buy
@ $38.92, valued at
$249.1k
|
|
| 03/08/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/07/2013 |
4
| BUCHEN DAVID A (Chief Legal Officer-Global&Sec) has filed a Form 4 on Actavis, Inc.|
Txns:
| Paid exercise price by delivering 3,896 shares
@ $86.46, valued at
$336.8k
|
|
| 03/05/2013 |
4
| BUCHEN DAVID A (Chief Legal Officer-Global&Sec) has filed a Form 4 on Actavis, Inc.|
Txns:
| Paid exercise price by delivering 5,030 shares
@ $85.54, valued at
$430.3k
|
|
| 08/24/2012 |
4
| BUCHEN DAVID A (Chief Legal Officer-Global&Sec) has filed a Form 4 on WATSON PHARMACEUTICALS INC|
Txns:
| Sold 24,294 shares
@ $81.56, valued at
$2M
Exercised 24,294 options to buy
@ $29.43, valued at
$715k
Exercised 706 options to buy
@ $29.43, valued at
$20.8k
|
|
| 05/30/2012 |
4
| BUCHEN DAVID A (Chief Legal Officer-Global&Sec) has filed a Form 4 on WATSON PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 6,366 shares
@ $72.67, valued at
$462.6k
Exercised 11,101 options to buy
@ $26.4, valued at
$293.1k
Exercised 3,899 options to buy
@ $26.4, valued at
$102.9k
|
|
| 03/16/2012 |
4
| BUCHEN DAVID A (Exec VP,General Counsel & Sec.) has filed a Form 4 on WATSON PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 2,473 shares
@ $59.21, valued at
$146.4k
|
|
| 03/12/2012 |
4
| BUCHEN DAVID A (Exec VP,General Counsel & Sec.) has filed a Form 4 on WATSON PHARMACEUTICALS INC|
Txns:
| Granted 8,356 shares
@ $0
Granted 7,698 shares
@ $0 |
|
| 08/29/2011 |
4
| BUCHEN DAVID A (Exec VP,General Counsel & Sec.) has filed a Form 4 on WATSON PHARMACEUTICALS INC|
Txns:
| Sold 17,500 shares
@ $65.5, valued at
$1.1M
Exercised 17,499 options to buy
@ $28.15, valued at
$492.6k
Exercised 1 options to buy
@ $28.15, valued at
$28.2 |
|
| 05/31/2011 |
4
| BUCHEN DAVID A (Exec VP,General Counsel & Sec.) has filed a Form 4 on WATSON PHARMACEUTICALS INC|
Txns:
| Sold 7,000 shares
@ $64.1, valued at
$448.7k
Exercised 1,400 options to buy
@ $54.48, valued at
$76.3k
Exercised 5,600 options to buy
@ $54.48, valued at
$305.1k
|
|
| 03/15/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/08/2011 |
4
| BUCHEN DAVID A (Sr. VP, General Counsel & Sec.) has filed a Form 4 on WATSON PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 2,747 shares
@ $56.79, valued at
$156k
|
|
| 09/02/2010 |
4
| BUCHEN DAVID A (Sr. VP, General Counsel & Sec.) has filed a Form 4 on WATSON PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 305 shares
@ $44.15, valued at
$13.5k
|
|
| 03/16/2010 |
4
| BUCHEN DAVID A (Sr. VP, General Counsel & Sec.) has filed a Form 4 on WATSON PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 2,751 shares
@ $41.37, valued at
$113.8k
|
|
| 02/26/2010 |
4
| BUCHEN DAVID A (Sr. VP, General Counsel & Sec.) has filed a Form 4 on WATSON PHARMACEUTICALS INC|
Txns:
| Granted 16,523 shares
@ $0 |
|
| 08/13/2009 |
4
| BUCHEN DAVID A (Sr. VP, General Counsel & Sec.) has filed a Form 4 on WATSON PHARMACEUTICALS INC |
| 03/06/2009 |
4
| BUCHEN DAVID A (Sr. VP, General Counsel & Sec.) has filed a Form 4 on WATSON PHARMACEUTICALS INC |